Wolff Wiese Magana’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-36,519
Closed -$468K 797
2021
Q4
$468K Sell
36,519
-388
-1% -$5.43K 0.3% 77
2021
Q3
$511K Buy
36,907
+79
+0.2% +$831 0.36% 71
2021
Q2
$380K Sell
36,828
-189
-0.5% -$1.87K 0.27% 85
2021
Q1
$358K Sell
37,017
-28,435
-43% -$284K 0.28% 75
2020
Q4
$471K Buy
+65,452
New +$434K 0.4% 64

Other funds holding APYX

Wolff Wiese Magana's APYX Position: Q1 2022 in Review

Wolff Wiese Magana sold out of Apyx Medical (APYX) in Q1 2022, closing a stake of 36,519 shares — an estimated $468K sold.

Wolff Wiese Magana first reported a position in APYX in Q4 2020 and held it in 5 quarters. The position peaked at $511K in Q3 2021. 71 funds tracked by Wall St. Rank hold APYX as of Q1 2022.

  • Wolff Wiese Magana reported no remaining Apyx Medical position as of Q1 2022 after selling out during the quarter.
  • Wolff Wiese Magana sold 36,519 Apyx Medical shares in Q1 2022, an estimated $468K.
  • Wolff Wiese Magana first reported a position in Apyx Medical in Q4 2020 and held it in 5 quarters.
  • Wolff Wiese Magana's Apyx Medical position peaked at $511K in Q3 2021.
  • 71 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2022.

Based on Wolff Wiese Magana's 13F filing for Q1 2022, filed 9 May 2022.